Global Lorlatinib Market Growth 2023-2029

March 2023 | 70 pages | ID: G455B101ADAEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

LPI (LP Information)' newest research report, the “Lorlatinib Industry Forecast” looks at past sales and reviews total world Lorlatinib sales in 2022, providing a comprehensive analysis by region and market sector of projected Lorlatinib sales for 2023 through 2029. With Lorlatinib sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lorlatinib industry.

This Insight Report provides a comprehensive analysis of the global Lorlatinib landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Lorlatinib portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Lorlatinib market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lorlatinib and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lorlatinib.

The global Lorlatinib market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Lorlatinib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Lorlatinib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Lorlatinib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Lorlatinib players cover Pfizer. etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Lorlatinib market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

• Tables 25mg
• Tables 100mg

Segmentation by application

• Squamous Cell Carcinoma of NSCLC
• Adenocarcinoma of NSCLC
• Large Cell Carcinoma of NSCLC

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Pfizer

Key Questions Addressed in this Report

What is the 10-year outlook for the global Lorlatinib market?

What factors are driving Lorlatinib market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Lorlatinib market opportunities vary by end market size?

How does Lorlatinib break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Lorlatinib Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Lorlatinib by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Lorlatinib by Country/Region, 2018, 2022 & 2029
2.2 Lorlatinib Segment by Type
  2.2.1 Tables 25mg
  2.2.2 Tables 100mg
2.3 Lorlatinib Sales by Type
  2.3.1 Global Lorlatinib Sales Market Share by Type (2018-2023)
  2.3.2 Global Lorlatinib Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Lorlatinib Sale Price by Type (2018-2023)
2.4 Lorlatinib Segment by Application
  2.4.1 Squamous Cell Carcinoma of NSCLC
  2.4.2 Adenocarcinoma of NSCLC
  2.4.3 Large Cell Carcinoma of NSCLC
2.5 Lorlatinib Sales by Application
  2.5.1 Global Lorlatinib Sale Market Share by Application (2018-2023)
  2.5.2 Global Lorlatinib Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Lorlatinib Sale Price by Application (2018-2023)

3 GLOBAL LORLATINIB BY COMPANY

3.1 Global Lorlatinib Breakdown Data by Company
  3.1.1 Global Lorlatinib Annual Sales by Company (2018-2023)
  3.1.2 Global Lorlatinib Sales Market Share by Company (2018-2023)
3.2 Global Lorlatinib Annual Revenue by Company (2018-2023)
  3.2.1 Global Lorlatinib Revenue by Company (2018-2023)
  3.2.2 Global Lorlatinib Revenue Market Share by Company (2018-2023)
3.3 Global Lorlatinib Sale Price by Company
3.4 Key Manufacturers Lorlatinib Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Lorlatinib Product Location Distribution
  3.4.2 Players Lorlatinib Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR LORLATINIB BY GEOGRAPHIC REGION

4.1 World Historic Lorlatinib Market Size by Geographic Region (2018-2023)
  4.1.1 Global Lorlatinib Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Lorlatinib Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Lorlatinib Market Size by Country/Region (2018-2023)
  4.2.1 Global Lorlatinib Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Lorlatinib Annual Revenue by Country/Region (2018-2023)
4.3 Americas Lorlatinib Sales Growth
4.4 APAC Lorlatinib Sales Growth
4.5 Europe Lorlatinib Sales Growth
4.6 Middle East & Africa Lorlatinib Sales Growth

5 AMERICAS

5.1 Americas Lorlatinib Sales by Country
  5.1.1 Americas Lorlatinib Sales by Country (2018-2023)
  5.1.2 Americas Lorlatinib Revenue by Country (2018-2023)
5.2 Americas Lorlatinib Sales by Type
5.3 Americas Lorlatinib Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Lorlatinib Sales by Region
  6.1.1 APAC Lorlatinib Sales by Region (2018-2023)
  6.1.2 APAC Lorlatinib Revenue by Region (2018-2023)
6.2 APAC Lorlatinib Sales by Type
6.3 APAC Lorlatinib Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Lorlatinib by Country
  7.1.1 Europe Lorlatinib Sales by Country (2018-2023)
  7.1.2 Europe Lorlatinib Revenue by Country (2018-2023)
7.2 Europe Lorlatinib Sales by Type
7.3 Europe Lorlatinib Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Lorlatinib by Country
  8.1.1 Middle East & Africa Lorlatinib Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Lorlatinib Revenue by Country (2018-2023)
8.2 Middle East & Africa Lorlatinib Sales by Type
8.3 Middle East & Africa Lorlatinib Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Lorlatinib
10.3 Manufacturing Process Analysis of Lorlatinib
10.4 Industry Chain Structure of Lorlatinib

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Lorlatinib Distributors
11.3 Lorlatinib Customer

12 WORLD FORECAST REVIEW FOR LORLATINIB BY GEOGRAPHIC REGION

12.1 Global Lorlatinib Market Size Forecast by Region
  12.1.1 Global Lorlatinib Forecast by Region (2024-2029)
  12.1.2 Global Lorlatinib Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Lorlatinib Forecast by Type
12.7 Global Lorlatinib Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Pfizer
  13.1.1 Pfizer Company Information
  13.1.2 Pfizer Lorlatinib Product Portfolios and Specifications
  13.1.3 Pfizer Lorlatinib Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Pfizer Main Business Overview
  13.1.5 Pfizer Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Lorlatinib Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Lorlatinib Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Tables 25mg
Table 4. Major Players of Tables 100mg
Table 5. Global Lorlatinib Sales by Type (2018-2023) & (K Pcs)
Table 6. Global Lorlatinib Sales Market Share by Type (2018-2023)
Table 7. Global Lorlatinib Revenue by Type (2018-2023) & ($ million)
Table 8. Global Lorlatinib Revenue Market Share by Type (2018-2023)
Table 9. Global Lorlatinib Sale Price by Type (2018-2023) & (USD/Pcs)
Table 10. Global Lorlatinib Sales by Application (2018-2023) & (K Pcs)
Table 11. Global Lorlatinib Sales Market Share by Application (2018-2023)
Table 12. Global Lorlatinib Revenue by Application (2018-2023)
Table 13. Global Lorlatinib Revenue Market Share by Application (2018-2023)
Table 14. Global Lorlatinib Sale Price by Application (2018-2023) & (USD/Pcs)
Table 15. Global Lorlatinib Sales by Company (2018-2023) & (K Pcs)
Table 16. Global Lorlatinib Sales Market Share by Company (2018-2023)
Table 17. Global Lorlatinib Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Lorlatinib Revenue Market Share by Company (2018-2023)
Table 19. Global Lorlatinib Sale Price by Company (2018-2023) & (USD/Pcs)
Table 20. Key Manufacturers Lorlatinib Producing Area Distribution and Sales Area
Table 21. Players Lorlatinib Products Offered
Table 22. Lorlatinib Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Lorlatinib Sales by Geographic Region (2018-2023) & (K Pcs)
Table 26. Global Lorlatinib Sales Market Share Geographic Region (2018-2023)
Table 27. Global Lorlatinib Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Lorlatinib Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Lorlatinib Sales by Country/Region (2018-2023) & (K Pcs)
Table 30. Global Lorlatinib Sales Market Share by Country/Region (2018-2023)
Table 31. Global Lorlatinib Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Lorlatinib Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Lorlatinib Sales by Country (2018-2023) & (K Pcs)
Table 34. Americas Lorlatinib Sales Market Share by Country (2018-2023)
Table 35. Americas Lorlatinib Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Lorlatinib Revenue Market Share by Country (2018-2023)
Table 37. Americas Lorlatinib Sales by Type (2018-2023) & (K Pcs)
Table 38. Americas Lorlatinib Sales by Application (2018-2023) & (K Pcs)
Table 39. APAC Lorlatinib Sales by Region (2018-2023) & (K Pcs)
Table 40. APAC Lorlatinib Sales Market Share by Region (2018-2023)
Table 41. APAC Lorlatinib Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Lorlatinib Revenue Market Share by Region (2018-2023)
Table 43. APAC Lorlatinib Sales by Type (2018-2023) & (K Pcs)
Table 44. APAC Lorlatinib Sales by Application (2018-2023) & (K Pcs)
Table 45. Europe Lorlatinib Sales by Country (2018-2023) & (K Pcs)
Table 46. Europe Lorlatinib Sales Market Share by Country (2018-2023)
Table 47. Europe Lorlatinib Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Lorlatinib Revenue Market Share by Country (2018-2023)
Table 49. Europe Lorlatinib Sales by Type (2018-2023) & (K Pcs)
Table 50. Europe Lorlatinib Sales by Application (2018-2023) & (K Pcs)
Table 51. Middle East & Africa Lorlatinib Sales by Country (2018-2023) & (K Pcs)
Table 52. Middle East & Africa Lorlatinib Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Lorlatinib Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Lorlatinib Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Lorlatinib Sales by Type (2018-2023) & (K Pcs)
Table 56. Middle East & Africa Lorlatinib Sales by Application (2018-2023) & (K Pcs)
Table 57. Key Market Drivers & Growth Opportunities of Lorlatinib
Table 58. Key Market Challenges & Risks of Lorlatinib
Table 59. Key Industry Trends of Lorlatinib
Table 60. Lorlatinib Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Lorlatinib Distributors List
Table 63. Lorlatinib Customer List
Table 64. Global Lorlatinib Sales Forecast by Region (2024-2029) & (K Pcs)
Table 65. Global Lorlatinib Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Lorlatinib Sales Forecast by Country (2024-2029) & (K Pcs)
Table 67. Americas Lorlatinib Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Lorlatinib Sales Forecast by Region (2024-2029) & (K Pcs)
Table 69. APAC Lorlatinib Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Lorlatinib Sales Forecast by Country (2024-2029) & (K Pcs)
Table 71. Europe Lorlatinib Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Lorlatinib Sales Forecast by Country (2024-2029) & (K Pcs)
Table 73. Middle East & Africa Lorlatinib Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Lorlatinib Sales Forecast by Type (2024-2029) & (K Pcs)
Table 75. Global Lorlatinib Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Lorlatinib Sales Forecast by Application (2024-2029) & (K Pcs)
Table 77. Global Lorlatinib Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Pfizer Basic Information, Lorlatinib Manufacturing Base, Sales Area and Its Competitors
Table 79. Pfizer Lorlatinib Product Portfolios and Specifications
Table 80. Pfizer Lorlatinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 81. Pfizer Main Business
Table 82. Pfizer Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Lorlatinib
Figure 2. Lorlatinib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Lorlatinib Sales Growth Rate 2018-2029 (K Pcs)
Figure 7. Global Lorlatinib Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Lorlatinib Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Tables 25mg
Figure 10. Product Picture of Tables 100mg
Figure 11. Global Lorlatinib Sales Market Share by Type in 2022
Figure 12. Global Lorlatinib Revenue Market Share by Type (2018-2023)
Figure 13. Lorlatinib Consumed in Squamous Cell Carcinoma of NSCLC
Figure 14. Global Lorlatinib Market: Squamous Cell Carcinoma of NSCLC (2018-2023) & (K Pcs)
Figure 15. Lorlatinib Consumed in Adenocarcinoma of NSCLC
Figure 16. Global Lorlatinib Market: Adenocarcinoma of NSCLC (2018-2023) & (K Pcs)
Figure 17. Lorlatinib Consumed in Large Cell Carcinoma of NSCLC
Figure 18. Global Lorlatinib Market: Large Cell Carcinoma of NSCLC (2018-2023) & (K Pcs)
Figure 19. Global Lorlatinib Sales Market Share by Application (2022)
Figure 20. Global Lorlatinib Revenue Market Share by Application in 2022
Figure 21. Lorlatinib Sales Market by Company in 2022 (K Pcs)
Figure 22. Global Lorlatinib Sales Market Share by Company in 2022
Figure 23. Lorlatinib Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Lorlatinib Revenue Market Share by Company in 2022
Figure 25. Global Lorlatinib Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Lorlatinib Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Lorlatinib Sales 2018-2023 (K Pcs)
Figure 28. Americas Lorlatinib Revenue 2018-2023 ($ Millions)
Figure 29. APAC Lorlatinib Sales 2018-2023 (K Pcs)
Figure 30. APAC Lorlatinib Revenue 2018-2023 ($ Millions)
Figure 31. Europe Lorlatinib Sales 2018-2023 (K Pcs)
Figure 32. Europe Lorlatinib Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Lorlatinib Sales 2018-2023 (K Pcs)
Figure 34. Middle East & Africa Lorlatinib Revenue 2018-2023 ($ Millions)
Figure 35. Americas Lorlatinib Sales Market Share by Country in 2022
Figure 36. Americas Lorlatinib Revenue Market Share by Country in 2022
Figure 37. Americas Lorlatinib Sales Market Share by Type (2018-2023)
Figure 38. Americas Lorlatinib Sales Market Share by Application (2018-2023)
Figure 39. United States Lorlatinib Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Lorlatinib Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Lorlatinib Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Lorlatinib Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Lorlatinib Sales Market Share by Region in 2022
Figure 44. APAC Lorlatinib Revenue Market Share by Regions in 2022
Figure 45. APAC Lorlatinib Sales Market Share by Type (2018-2023)
Figure 46. APAC Lorlatinib Sales Market Share by Application (2018-2023)
Figure 47. China Lorlatinib Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Lorlatinib Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Lorlatinib Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Lorlatinib Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Lorlatinib Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Lorlatinib Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Lorlatinib Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Lorlatinib Sales Market Share by Country in 2022
Figure 55. Europe Lorlatinib Revenue Market Share by Country in 2022
Figure 56. Europe Lorlatinib Sales Market Share by Type (2018-2023)
Figure 57. Europe Lorlatinib Sales Market Share by Application (2018-2023)
Figure 58. Germany Lorlatinib Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Lorlatinib Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Lorlatinib Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Lorlatinib Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Lorlatinib Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Lorlatinib Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Lorlatinib Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Lorlatinib Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Lorlatinib Sales Market Share by Application (2018-2023)
Figure 67. Egypt Lorlatinib Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Lorlatinib Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Lorlatinib Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Lorlatinib Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Lorlatinib Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Lorlatinib in 2022
Figure 73. Manufacturing Process Analysis of Lorlatinib
Figure 74. Industry Chain Structure of Lorlatinib
Figure 75. Channels of Distribution
Figure 76. Global Lorlatinib Sales Market Forecast by Region (2024-2029)
Figure 77. Global Lorlatinib Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Lorlatinib Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Lorlatinib Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Lorlatinib Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Lorlatinib Revenue Market Share Forecast by Application (2024-2029)